May 21, 2018
The House of Representatives will soon vote on a companion bill to S. 204, the Right to Try Act. This bill would prevent the federal government from impeding patients’ access to treatments that have successfully completed the Food and Drug Administration’s (FDA) first phase of trials. For terminally-ill patients, these treatments are their last hope when nothing else works.
September 14, 2017
Lawyers and allied interest groups have long enriched themselves at taxpayers’ expense. But usually, it has been by bringing lawsuits, not defending them.
The Ohio Drug Price Standards Initiative might change that. If passed by voters, it would give its sponsors taxpayer money to hire unnecessary...
February 7, 2017
Hans Rosling, the Swedish doctor and professor who saved countless lives in the world’s poorest countries (and gave TED talks), has died of pancreatic cancer. In December, Nature had an interesting feature with him, discussing his life’s work.
Rosling was an antidote to uninformed pessimism. As Nature...
January 18, 2017
If all goes according to President-elect Donald Trump’s plan, the next Secretary of the Department of Health and Human Services (HHS) will be Rep. Tom Price. While Price is perhaps best known for his opposition to the...
November 28, 2016
This week on RealClear Radio Hour, Drs. Debra Patt and Kerry Emanuel discuss the politics of cancer care, chaos theory, and climate science.
We open the show with Dr. Debra Patt, practicing oncologist and Vice President of Texas Oncology. Debra explains how the well-intentioned federal 340B Drug Discount Program is actually driving up cancer care costs. With preferred vendor hospitals applying their 30-50% drug discounts to all patients, not just the underserved, industry-wide prices are being forced up to subsidize the program. On the whole, however, she is optimistic about the diagnostic innovations, therapeutic success, and a drastic drop in cancer mortality rates.
September 7, 2016
Democrats in the Senate have blocked a bill that would have provided federal funds to combat the spread of the Zika virus, reports The Hill. As a result, supporters were unable to assemble the 60 votes necessary to end debate and move forward to a vote...
September 6, 2016
Last Friday, Hillary Clinton announced a new plan to “respond to unjustified price hikes” on certain pharmaceutical drugs. This comes after weeks of public debate over the rising price of...
September 5, 2016
In this episode of RealClear Radio Hour, we discuss the fiascos of government overreach and overregulation—on American Indian reservations, in the EpiPen saga, and with political intimidation campaigns.
Naomi Schaefer Riley, New York Post columnist and author of The New Trail of Tears: How Washington Is Destroying American Indians joins me at the top of the hour. Naomi details how federal policies have consigned Native Americans to poverty and contributed to their high rates of suicide, domestic abuse, gang violence, unemployment, and drug and alcohol epidemics. She argues for repealing both stifling tribal regulations and the loophole economy regulatory exemptions, instead allowing for true property rights and access...
August 9, 2016
August 5, 2016
After years of waiting and fighting, the new rules put forth by the U.S. Food and Drug Administration (FDA) on electronic cigarettes and other non-cigarette products go into effect Monday, August 8th, 2016. The rule change, purportedly to...